High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
High mobility group box 1 protein (HMGB1) is secreted by immune cells like macrophages, monocytes, and dendritic cells through a leaderless secretory pathway. Activated macrophages and monocytes secrete HMGB1.
The HMGB1 pipeline market research report provides comprehensive information on the HMGB1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, the latest news as well as press releases. Additionally, the report provides an overview of key players involved in High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) targeted therapeutics development with respective active and dormant or discontinued projects.
Key Therapy Areas in the HMGB1 Pipeline Products Market
The key therapy areas in the HMGB1 pipeline products market are infectious disease, central nervous system, oncology, cardiovascular, gastrointestinal, dermatology, and musculoskeletal disorders.
HMGB1 Pipeline Products Market Analysis by Therapy Areas
For more therapy area insights, download a free report sample
Key Mechanisms of Action in the HMGB1 Pipeline Products Market
The key mechanisms of action in the HMGB1 pipeline products market are High Mobility Group Protein B1 Inhibitor, High Mobility Group Protein B1 Activator, and High Mobility Group Protein B1 Replacement.
HMGB1 Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights, download a free report sample
Key Routes of Administration in the HMGB1 Pipeline Products Market
The key routes of administration in the HMGB1 pipeline products market are intravenous drip, intravenous bolus, subcutaneous, and intravenous.
HMGB1 Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the HMGB1 Pipeline Products Market
The key molecule types in the HMGB1 pipeline products market are peptide, polysaccharide, small molecule, monoclonal antibody, oncolytic virus, protein, and recombinant protein.
HMGB1 Pipeline Products Market Analysis by Molecule Types
For more molecule type insights, download a free report sample
Major Companies in the HMGB1 Pipeline Products Market
The major companies in the HMGB1 pipeline products market are 180 Life Sciences Corp, Chimerix Inc, KaliVir Immunotherapeutics Inc, Shionogi & Co Ltd, and TheraSource LLC.
HMGB1 Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
HMGB1 Pipeline Products Market Report Overview
Key Therapy Areas | Infectious Disease, Central Nervous System, Oncology, Cardiovascular, Gastrointestinal, Dermatology, and Musculoskeletal Disorders |
Key Mechanisms of Action | High Mobility Group Protein B1 Inhibitor, High Mobility Group Protein B1 Activator, and High Mobility Group Protein B1 Replacement |
Key Routes of Administration | Intravenous Drip, Intravenous Bolus, Subcutaneous, and Intravenous |
Key Molecule Type | Peptide, Polysaccharide, Small Molecule, Monoclonal Antibody, Oncolytic Virus, Protein, and Recombinant Protein |
Major Companies | 180 Life Sciences Corp, Chimerix Inc, KaliVir Immunotherapeutics Inc, Shionogi & Co Ltd, and TheraSource LLC |
Scope
- The report provides a snapshot of the global therapeutic landscape for High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1)
- The report reviews High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing, and collaboration details & other developmental activities
- The report reviews key players involved in High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) targeted therapeutics and enlists all their major and minor projects
- The report assesses High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews the latest news and deals related to High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding the High Mobility Group Protein B1 (High Mobility Group Protein 1 or High Mobility Group Protein Box 1 or HMGB1) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Chimerix Inc
KaliVir Immunotherapeutics Inc
Shionogi & Co Ltd
TheraSource LLC
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key therapy areas in the HMGB1 pipeline products market?
The key therapy areas in the HMGB1 pipeline products market are infectious disease, central nervous system, oncology, cardiovascular, gastrointestinal, dermatology, and musculoskeletal disorders.
-
What are the key mechanisms of action in the HMGB1 pipeline products market?
The key mechanisms of action in the HMGB1 pipeline products market are High Mobility Group Protein B1 Inhibitor, High Mobility Group Protein B1 Activator, and High Mobility Group Protein B1 Replacement.
-
What are the key routes of administration in the HMGB1 pipeline products market?
The key routes of administration in the HMGB1 pipeline products market are intravenous drip, intravenous bolus, subcutaneous, and intravenous.
-
What are the key molecule types in the HMGB1 pipeline products market?
The key molecule types in the HMGB1 pipeline products market are peptide, polysaccharide, small molecule, monoclonal antibody, oncolytic virus, protein, and recombinant protein.
-
Which are the major companies in the HMGB1 pipeline products market?
The major companies in the HMGB1 pipeline products market are 180 Life Sciences Corp, Chimerix Inc, KaliVir Immunotherapeutics Inc, Shionogi & Co Ltd, and TheraSource LLC.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.